Table 3.
Associations between adiposity markers and secondary outcome: time to next relapse
UNIVARIATE ASSOCIATIONS | MULTIVARIATE ASSOCIATIONS | |||||
---|---|---|---|---|---|---|
All subjects | Women | Men | All subjects | Women | Men | |
Time to next relapse (N=163) – a positive value indicates worsening function | ||||||
Adiposity Markers | ||||||
Leptin | 0.97 (0.66) | 0.99 (0.88) | 0.93 (0.82) | |||
a-FABP | 0.95 (0.47) | 0.93 (0.42) | 1.10 (0.54) | 0.96 (0.51) | 0.93 (0.42) | 1.12 (0.47) |
Additional markers | ||||||
25(OH)VitD | 1.12 (0.26) | 1.15 (0.24) | 0.96 (0.86) | 1.11 (0.29) | 1.13 (0.32) | 0.96 (0.86) |
Testosterone | 1.00 (0.98) | 1.10 (0.28) | 1.01 (0.69) | 1.00 (0.96) | 1.10 (0.32) | 1.01 (0.54) |
25(OH)VitD: 25-hydroxy-vitamin D; a-FABP: adipocyte-fatty acid binding protein
Time to next relapse: cox proportional hazards ratio increase in time to next relapse for one unit increase in each of the hormone measures (p-value). Adjusted for age, disease duration and type.